Abstract

The present disclosure relates to novel crystalline forms of Elacestrant dihydrochloride which is chemically known as (6R) -6- (2- (N- (4- (2-(ethyl amino) ethyl) benzyl) -N- ethyl amino) - 4- methoxy phenyl) - 5, 6, 7, 8-tetrahydrona phthalen-2-ol dihydrochloride of formula-1a and their processes for the preparation thereof

Formula-1a.

The present disclosure also relates to novel salts of Elacestrant of Formula-1, represented by the following structural formula and processes for the preparation thereof.

Formula-1.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS